Target intelligence / Profile preview

Extracellular matrix scaffold (for wound healing) (ECM scaffold)

Target
ECM scaffold
Molecular classification
Other (biomaterial, scaffold, tissue engineering device; not a molecular classification)
01

Overview

Extracellular matrix scaffolds for wound healing are acellular biomaterials, typically derived from decellularized tissues such as dermis, small intestine submucosa, or amniotic membrane, designed to mimic the natural ECM’s three-dimensional structure and bioactivity. Upon implantation, these scaffolds provide a supportive environment for host cell infiltration, migration, and proliferation, facilitate angiogenesis and granulation tissue formation, and modulate immune responses by promoting anti-inflammatory and pro-regenerative macrophage phenotypes. ECM scaffolds are widely used for chronic wound management, burn repair, and tissue engineering but are not molecular drug targets; rather, they serve as advanced wound dressings and tissue engineering materials.

Other names
Acellular dermal matrixDecellularized ECM scaffoldSmall intestinal submucosa scaffoldAmniotic membrane scaffold
02

Mechanism of action

Provides a structural substrate for cell ingrowth, migration, and attachment. Releases bioactive molecules after degradation. Modulates local immune response (promotes M2 macrophage phenotype, Th2 response). Acts as a reservoir for growth factors and bioactive proteins.

03

Biological functions

Structural support for cell adhesion and migrationPromotion of cell proliferationFacilitation of angiogenesisModulation of immune response (e.g., polarization of macrophages to M2 phenotype for healing)Enhancement of extracellular matrix production and remodeling
04

Disease associations

Wound healing (chronic and acute wounds)Tissue regenerationInflammation modulationScar reduction
05

Safety considerations

Risk of immunological rejection if allogenic/xenogenic tissue usedPotential for poor mechanical strength or uncontrollable degradation leading to poor clinical outcomesInfection risk, especially if poorly sterilized or improperly processedPossibility of inappropriate inflammatory or fibrotic responses (promoting scar formation)
06

Biomarkers

Macrophage phenotype (M1/M2 polarization) in the wound site can be used as a biomarker for efficacyExpression of collagen I and fibronectin as markers of remodelingGranulation tissue formation

Beyond the preview

Go deeper on Extracellular matrix scaffold (for wound healing) (ECM scaffold).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix scaffold (for wound healing) (ECM scaffold).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call